These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27240248)

  • 1. New perspectives on the conservative management of osteoradionecrosis of the mandible: A literature review.
    Costa DA; Costa TP; Netto EC; Joaquim N; Ventura I; Pratas AC; Winckler P; Silva IP; Pinho AC; Sargento IG; Guerreiro FG; Moreira AR
    Head Neck; 2016 Nov; 38(11):1708-1716. PubMed ID: 27240248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for prospective randomised assessor-blinded pilot study comparing hyperbaric oxygen therapy with PENtoxifylline+TOcopherol± CLOdronate for the management of early osteoradionecrosis of the mandible.
    Bulsara VM; Bulsara MK; Lewis E
    BMJ Open; 2019 Mar; 9(3):e026662. PubMed ID: 30837258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of osteoradionecrosis of the jaws--a review.
    Rice N; Polyzois I; Ekanayake K; Omer O; Stassen LF
    Surgeon; 2015 Apr; 13(2):101-9. PubMed ID: 25084627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline-tocopherol-clodronate combination: A novel treatment for osteoradionecrosis of the temporal bone.
    Glicksman JT; Khalili S; Fung K; Parnes LS; Agrawal SK
    Head Neck; 2015 Dec; 37(12):E191-3. PubMed ID: 25821165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial.
    Delanian S; Chatel C; Porcher R; Depondt J; Lefaix JL
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):832-9. PubMed ID: 20638190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, α-tocopherol, and clodronate.
    Rivero JA; Shamji O; Kolokythas A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Nov; 124(5):464-471. PubMed ID: 29103566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results.
    Robard L; Louis MY; Blanchard D; Babin E; Delanian S
    Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):333-338. PubMed ID: 24993781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pentoxifylline-tocopherol-clodronate in mandibular osteoradionecrosis.
    Dissard A; P Dang N; Barthelemy I; Delbet C; Puechmaille M; Depeyre A; Pereira B; Martin F; Guillemin F; Biau J; Mirafzal S; Mom T; Gilain L; Saroul N
    Laryngoscope; 2020 Nov; 130(11):E559-E566. PubMed ID: 31747060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic modalities in the treatment of osteoradionecrosis of the jaw.
    McCaul JA
    Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):247-52. PubMed ID: 24794269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review.
    Martos-Fernández M; Saez-Barba M; López-López J; Estrugo-Devesa A; Balibrea-Del-Castillo JM; Bescós-Atín C
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):431-439. PubMed ID: 29550081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive factors for mandibular osteoradionecrosis after irradiation of head and neck cancers].
    Dutheil F; Guillemin F; Biau J; Pham-Dang N; Saroul N; Clavère P; Lapeyre M
    Cancer Radiother; 2021 Jul; 25(5):484-493. PubMed ID: 33836955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in the medical management of osteoradionecrosis using triple therapy.
    Dhanda J; Rennie L; Shaw R
    Br J Oral Maxillofac Surg; 2018 Jun; 56(5):401-405. PubMed ID: 29650474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges threaten, opportunity awaits hyperbaric medicine and the head and neck cancer patient.
    Clarke R
    Undersea Hyperb Med; 2019 Jun-Jul-Aug - Third Quarter; 46(4):385-397. PubMed ID: 31509895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of pentoxifylline and tocopherol in the management of osteoradionecrosis.
    Patel V; Gadiwalla Y; Sassoon I; Sproat C; Kwok J; McGurk M
    Br J Oral Maxillofac Surg; 2016 Apr; 54(3):342-5. PubMed ID: 26794083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of pentoxifylline/tocopherol combination in the treatment of osteoradionecrosis.
    Hayashi M; Pellecer M; Chung E; Sung E
    Spec Care Dentist; 2015; 35(6):268-71. PubMed ID: 26084886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for pentoxifylline and tocopherol in the management of advanced osteoradionecrosis of the jaws with pathological fractures? Case reports and review of the literature.
    Breik O; Tocaciu S; Briggs K; Tasfia Saief S; Richardson S
    Int J Oral Maxillofac Surg; 2019 Aug; 48(8):1022-1027. PubMed ID: 30981534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern management of osteoradionecrosis.
    Raggio BS; Winters R
    Curr Opin Otolaryngol Head Neck Surg; 2018 Aug; 26(4):254-259. PubMed ID: 29727306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible: experience from a regional head and neck unit.
    D'Souza J; Lowe D; Rogers SN
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):356-62. PubMed ID: 24480621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial.
    Delanian S; Depondt J; Lefaix JL
    Head Neck; 2005 Feb; 27(2):114-23. PubMed ID: 15641107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of hyperbaric oxygen therapy related to the clinical stage of osteoradionecrosis of the mandible.
    Dieleman FJ; Phan TTT; van den Hoogen FJA; Kaanders JHAM; Merkx MAW
    Int J Oral Maxillofac Surg; 2017 Apr; 46(4):428-433. PubMed ID: 28043745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.